NewYork-Presbyterian/Columbia surgeons perform first 'ex vivo' lung ... EurekAlert (press release) The Hospital has been on the forefront of developing and improving anti-rejection medications (immunosuppressants), minimally invasive surgery for living donors, genetic methods to detect transplant rejection, strategies to increase opportunities for ... |
